Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34043 | 117 | 16.5 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 1 | 3 | CHEMISTRY, ORGANIC//TETRAHEDRON LETTERS//JOURNAL OF ORGANIC CHEMISTRY | 237069 |
| 3914 | 2 | THIOCYANATION//ARYL THIOCYANATES//POLYTHIOCYANOGEN | 808 |
| 34043 | 1 | LOXOPROFEN//CS 670//PELUBIPROFEN | 117 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | LOXOPROFEN | authKW | 853486 | 9% | 30% | 11 |
| 2 | CS 670 | authKW | 587221 | 3% | 75% | 3 |
| 3 | PELUBIPROFEN | authKW | 587221 | 3% | 75% | 3 |
| 4 | 258 1CHOME | address | 521976 | 2% | 100% | 2 |
| 5 | ALPHA BETA KETOALKENE | authKW | 347983 | 2% | 67% | 2 |
| 6 | 13 14 DIHYDRO 15 KETOPROSTAGLANDIN | authKW | 260988 | 1% | 100% | 1 |
| 7 | 15 KETOPROSTAGLANDIN | authKW | 260988 | 1% | 100% | 1 |
| 8 | 15 KETOPROSTAGLANDIN DELTA 13 REDUCTASE PGR | authKW | 260988 | 1% | 100% | 1 |
| 9 | 15 KETOPROSTAGLANDIN DELTA13 REDUCTASE | authKW | 260988 | 1% | 100% | 1 |
| 10 | 2 ARYLPROPIONIC ACID DERIVATIVE | authKW | 260988 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Crystallography | 1684 | 32% | 0% | 38 |
| 2 | Pharmacology & Pharmacy | 319 | 32% | 0% | 37 |
| 3 | Chemistry, Medicinal | 295 | 15% | 0% | 18 |
| 4 | Chemistry, Multidisciplinary | 94 | 21% | 0% | 24 |
| 5 | Chemistry, Organic | 53 | 11% | 0% | 13 |
| 6 | Chemistry, Analytical | 51 | 10% | 0% | 12 |
| 7 | Ophthalmology | 21 | 4% | 0% | 5 |
| 8 | Biochemical Research Methods | 12 | 4% | 0% | 5 |
| 9 | Toxicology | 9 | 3% | 0% | 4 |
| 10 | Pathology | 5 | 3% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | 258 1CHOME | 521976 | 2% | 100% | 2 |
| 2 | CHEM S HIROMACHI 1CHOME SHINAGAWA KU | 260988 | 1% | 100% | 1 |
| 3 | CLINIAL CLIN PHARMACOL THER EUT | 260988 | 1% | 100% | 1 |
| 4 | GALEN TECN FARMACEUT | 260988 | 1% | 100% | 1 |
| 5 | CHEM S SHINAGAWA KU | 149133 | 2% | 29% | 2 |
| 6 | ZHEJIANG UNIV ECOLE NORMOLE SUPER JOINT MED C | 130493 | 1% | 50% | 1 |
| 7 | KYUNG HEE DRUG ANAL | 86995 | 1% | 33% | 1 |
| 8 | 258 HIROMACHI 1CHOME | 65245 | 1% | 25% | 1 |
| 9 | NEW LEAD S 1258 HIROMACHI SHINAGAWA KU | 52196 | 1% | 20% | 1 |
| 10 | BIOEQUIVALENCE BRIDGING STUDY | 34795 | 2% | 7% | 2 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS | 2535 | 9% | 0% | 10 |
| 2 | RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY | 1254 | 2% | 0% | 2 |
| 3 | ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 1231 | 8% | 0% | 9 |
| 4 | ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 1227 | 8% | 0% | 9 |
| 5 | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 1109 | 1% | 0% | 1 |
| 6 | DRUG METABOLISM AND DISPOSITION | 863 | 4% | 0% | 5 |
| 7 | ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY | 802 | 5% | 0% | 6 |
| 8 | CHIRALITY | 766 | 3% | 0% | 3 |
| 9 | JOURNAL OF PHARMACEUTICAL SCIENCES | 576 | 4% | 0% | 5 |
| 10 | JAPANESE JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH | 504 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | KASHIF, M , NISAR-UR-RAHMAN , IDREES, HA , ASLAM, I , IQBAL, SM , MUSTAFA, R , (2013) HPL-UV DETECTION METHOD FOR QUANTIFICATION OF LOXOPROFEN IN HUMAN PLASMA WITH LIQUID-LIQUID EXTRACTION TECHNIQUE: APPLICATION IN PHARMACOKINETIC STUDY.LATIN AMERICAN JOURNAL OF PHARMACY. VOL. 32. ISSUE 4. P. 587-592 | 13 | 81% | 0 |
| 2 | LEE, HW , JI, HY , SOHN, DH , KIM, SM , LEE, YB , LEE, HS , (2009) LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY METHOD OF LOXOPROFEN IN HUMAN PLASMA.BIOMEDICAL CHROMATOGRAPHY. VOL. 23. ISSUE 7. P. 714-718 | 10 | 77% | 3 |
| 3 | CHO, HY , PARK, CH , LEE, YB , (2006) DIRECT AND SIMULTANEOUS ANALYSIS OF LOXOPROFEN AND ITS DIASTEREOMETRIC ALCOHOL METABOLITES IN HUMAN SERUM BY ON-LINE COLUMN SWITCHING LIQUID CHROMATOGRAPHY AND ITS APPLICATION TO A PHARMACOKINETIC STUDY.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 835. ISSUE 1-2. P. 27 -34 | 8 | 80% | 9 |
| 4 | JASINSKI, JP , BUTCHER, RJ , SWAMY, MT , NARAYANA, B , SAROJINI, BK , YATHIRAJAN, HS , (2010) CRYSTAL STRUCTURE OF [4-(METHYLSULFANYL)PHENYL]ACETIC ACID.JOURNAL OF CHEMICAL CRYSTALLOGRAPHY. VOL. 40. ISSUE 1. P. 25 -28 | 8 | 73% | 2 |
| 5 | RYU, JH , PARK, JS , JO, MH , KIM, JI , SHIM, WS , KIM, BH , YIM, SV , HONG, J , LEE, KT , (2015) DEVELOPMENT AND VALIDATION OF AN LC-MS/MS METHOD FOR THE DETERMINATION OF PELUBIPROFEN AND ITS ACTIVE METABOLITE, TRANS-ALCOHOL, IN HUMAN PLASMA AND ITS APPLICATION TO PHARMACOKINETIC STUDY.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 983. ISSUE . P. 62 -67 | 7 | 70% | 2 |
| 6 | CHOO, KS , KIM, IW , JUNG, JK , SUH, YG , CHUNG, SJ , LEE, MH , SHIM, CK , (2001) SIMULTANEOUS DETERMINATION OF LOXOPROFEN AND ITS DIASTEREOMERIC ALCOHOL METABOLITES IN HUMAN PLASMA AND URINE BY A SIMPLE HPLC-UV DETECTION METHOD.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 25. ISSUE 3-4. P. 639-650 | 7 | 100% | 14 |
| 7 | KIM, IW , CHUNG, SJ , SHIM, CK , (2002) ALTERED METABOLISM OF ORALLY ADMINISTERED LOXOPROFEN IN HUMAN SUBJECTS AFTER AN ORAL ADMINISTRATION OF LOXOPROFEN FOR THREE CONSECUTIVE DAYS FOLLOWED BY A SEVEN-DAY WASHOUT.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 91. ISSUE 4. P. 973-979 | 8 | 80% | 2 |
| 8 | RIENDEAU, D , SALEM, M , STYHLER, A , OUELLET, M , MANCINI, JA , LI, CS , (2004) EVALUATION OF LOXOPROFEN AND ITS ALCOHOL METABOLITES FOR POTENCY AND SELECTIVITY OF INHIBITION OF CYCLOOXYGENASE-2.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 14. ISSUE 5. P. 1201-1203 | 9 | 53% | 7 |
| 9 | HELMY, SA , (2013) PHARMACOKINETICS AND BIOEQUIVALENCE EVALUATION OF 2 LOXOPROFEN TABLETS IN HEALTHY EGYPTIAN MALE VOLUNTEERS.CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. VOL. 2. ISSUE 2. P. 173-177 | 6 | 60% | 0 |
| 10 | HATA, T , OHASHI, Y , SASADA, Y , (1987) NONSTEROIDAL ANTIINFLAMMATORY DRUGS .6. THE CRYSTAL AND MOLECULAR-STRUCTURE OF (+/-)-(2SSTAR)-2-[4-((1SSTAR)-2-OXOCYCLOPENTYLMETHYL)PHENYL]-PROPIONICACID AND FORCE-FIELD CALCULATIONS.BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN. VOL. 60. ISSUE 10. P. 3535 -3539 | 10 | 91% | 0 |
Classes with closest relation at Level 1 |